As Japan’s nuclear crisis deepens, Wall Street may begin to focus on a small group of almost-ignored young biotechs. Known as the bio-defense group, these firms develop products that help protect the population from radiation l…
Two biotechs, SIGA and PharmAthene, vying to establish a foothold in the potentially vast biodefense market are in the midst of duking it out in a multibillion dollar legal battle. The crux of the dispute is a smallpox vaccine …
In the biggest Blogwatch ever, some of day’s top stories for investors, including how the Beatles on iTunes could have huge significance for the stock market; why insider trading might be difficult to prosecute; and the best IP…